Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073224894> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2073224894 endingPage "692" @default.
- W2073224894 startingPage "686" @default.
- W2073224894 abstract "This study describes characteristics of a human bladder cancer cell line J82/MMC that is 6-fold more resistant to mitomycin C (MMC) than the parental cells. The J82/MMC sub line was isolated by repeated continuous exposures of the J82/WT cells to increasing concentrations of MMC. The J82/MMC cell line showed (1) collateral sensitivity to taxol, 5-FU and topoisomerase II inhibitors; and (2) cross-resistance to cisplatin, melphalan and MMC analogues BMY 25282 and BMY 25067. Levels of two key MMC activation enzymes, NADPH cytochrome P450 reductase and DT-diaphorase, were significantly lower in J82/MMC cells compared with J82/WT, suggesting that lower sensitivity of J82/MMC cells to MMC may result from deficient drug activation. Further support is indicated by: 1) reduction in the differential in toxicity between the 2 cell lines by BMY 25282; and 2) a higher effect of DT-diaphorase inhibitor dicumarol on the wild-type cells compared with J82/MMC. Although glutathione (GSH) levels did not differ in these cells, a small but significant increase in GSH transferase (GST) activity was noticed in J82/MMC cells. GST inhibitor ethacrynic acid significantly enhanced MMC cytotoxicity in the J82/MMC cell line. A small but significant increase in the level of anti-oxidative enzyme catalase, but not GSH peroxidase, was also observed in J82/MMC cell line compared with J82/WT. Thus, the possibility that relatively lower sensitivity of J82/MMC cells to MMC may result from reduced oxygen radical generation cannot be ruled out. MMC-induced DNA interstrand cross-linking was markedly lower in the J82/MMC cell line compared with J82/WT. Our results suggest that the MMC resistance in the J82/MMC cell line may be multifactorial." @default.
- W2073224894 created "2016-06-24" @default.
- W2073224894 creator A5018863217 @default.
- W2073224894 creator A5019588157 @default.
- W2073224894 creator A5029866856 @default.
- W2073224894 date "1994-09-01" @default.
- W2073224894 modified "2023-09-25" @default.
- W2073224894 title "Characterization of a human bladder cancer cell line selected for resistance to mitomycin C" @default.
- W2073224894 cites W1581414347 @default.
- W2073224894 cites W1583228069 @default.
- W2073224894 cites W1680799029 @default.
- W2073224894 cites W1966120234 @default.
- W2073224894 cites W1979578283 @default.
- W2073224894 cites W1982189944 @default.
- W2073224894 cites W1985138514 @default.
- W2073224894 cites W1987789336 @default.
- W2073224894 cites W2006370393 @default.
- W2073224894 cites W2008357139 @default.
- W2073224894 cites W2026880256 @default.
- W2073224894 cites W2026889103 @default.
- W2073224894 cites W2028427446 @default.
- W2073224894 cites W2051064630 @default.
- W2073224894 cites W2090082360 @default.
- W2073224894 cites W2100577791 @default.
- W2073224894 cites W2315622565 @default.
- W2073224894 cites W4293247451 @default.
- W2073224894 cites W956554017 @default.
- W2073224894 doi "https://doi.org/10.1002/ijc.2910580512" @default.
- W2073224894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8077054" @default.
- W2073224894 hasPublicationYear "1994" @default.
- W2073224894 type Work @default.
- W2073224894 sameAs 2073224894 @default.
- W2073224894 citedByCount "31" @default.
- W2073224894 countsByYear W20732248942012 @default.
- W2073224894 countsByYear W20732248942015 @default.
- W2073224894 countsByYear W20732248942019 @default.
- W2073224894 countsByYear W20732248942020 @default.
- W2073224894 countsByYear W20732248942022 @default.
- W2073224894 crossrefType "journal-article" @default.
- W2073224894 hasAuthorship W2073224894A5018863217 @default.
- W2073224894 hasAuthorship W2073224894A5019588157 @default.
- W2073224894 hasAuthorship W2073224894A5029866856 @default.
- W2073224894 hasConcept C141071460 @default.
- W2073224894 hasConcept C2779338040 @default.
- W2073224894 hasConcept C502942594 @default.
- W2073224894 hasConcept C54355233 @default.
- W2073224894 hasConcept C71924100 @default.
- W2073224894 hasConcept C81885089 @default.
- W2073224894 hasConcept C86803240 @default.
- W2073224894 hasConcept C98274493 @default.
- W2073224894 hasConceptScore W2073224894C141071460 @default.
- W2073224894 hasConceptScore W2073224894C2779338040 @default.
- W2073224894 hasConceptScore W2073224894C502942594 @default.
- W2073224894 hasConceptScore W2073224894C54355233 @default.
- W2073224894 hasConceptScore W2073224894C71924100 @default.
- W2073224894 hasConceptScore W2073224894C81885089 @default.
- W2073224894 hasConceptScore W2073224894C86803240 @default.
- W2073224894 hasConceptScore W2073224894C98274493 @default.
- W2073224894 hasIssue "5" @default.
- W2073224894 hasLocation W20732248941 @default.
- W2073224894 hasLocation W20732248942 @default.
- W2073224894 hasOpenAccess W2073224894 @default.
- W2073224894 hasPrimaryLocation W20732248941 @default.
- W2073224894 hasRelatedWork W1484554393 @default.
- W2073224894 hasRelatedWork W1540912851 @default.
- W2073224894 hasRelatedWork W1839712612 @default.
- W2073224894 hasRelatedWork W2019257734 @default.
- W2073224894 hasRelatedWork W2066596647 @default.
- W2073224894 hasRelatedWork W2130659749 @default.
- W2073224894 hasRelatedWork W2328629072 @default.
- W2073224894 hasRelatedWork W2329885233 @default.
- W2073224894 hasRelatedWork W2353067691 @default.
- W2073224894 hasRelatedWork W2989770940 @default.
- W2073224894 hasVolume "58" @default.
- W2073224894 isParatext "false" @default.
- W2073224894 isRetracted "false" @default.
- W2073224894 magId "2073224894" @default.
- W2073224894 workType "article" @default.